News
The warning follows the death of a 29 year-old man who suffered a fatal cardiac arrest after miscalculating the his dose of ...
Discover why synthetic food dyes are being phased out in the US, how major brands are responding, and what challenges the ...
The U.S. Food and Drug Administration is revising the labeling of all extended-release attention-deficit/hyperactivity ...
10h
Health and Me on MSNFDA Mandates ADHD Drug Labels To Warn Of Weight Loss RiskThe FDA now requires ADHD extended-release drug labels to warn of weight loss risks in children under 6, urging monitoring ...
The US Food and Drug Administration’s top vaccine official overrode agency experts in May to recommend against the broad use ...
Labels of all extended-release stimulants indicated for ADHD -- including certain formulations of amphetamine and ...
Merck's Winrevair gains FDA priority review for PAH label update after ZENITH trial shows major reduction in serious events and strong clinical impact.
Explore 5 major types of food safety issues that the FDA routinely monitors, including foodborne pathogens and food fraud.
Regeneron, playing catch up with J&J and Pfizer, wins FDA approval for Lynozyfic in multiple myeloma
Another BCMA-targeted agent has arrived for the treatment of multiple myeloma. | After a delay, Regeneron’s BCMA-directed ...
The FDA now requires updated labeling for all extended-release stimulant medications used to treat attention deficit hyperactivity disorder, warning of increased risk of weight loss and other side ...
The U.S. Food and Drug Administration is now requiring two common COVID-19 vaccines to update their warning labels to include ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results